Universal API Implementation Guide - Local Development build (v1.1.20) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

Release 2024 Oct 4

Ocrevus Copay Update

IMPORTANT:

• The Ocrevus Copay questionnaire is being updated to reflect the addition of new linkId "ocrevus-form-of-ocrevus" (see table below).
• Validation for new Ocrevus Copay questionnaire "ocrevus-form-of-ocrevus" will be deployed by CRX on 10/8/2024. This means that if an Ocrevus Copay enrollment does not include the questionnaireResponse for "ocrevus-form-of-ocrevus" in the FHIR bundle, then CRX will generate an error and enrollment will not be processed.
  
  

Access to Ocrevus Copay Questionnaire

Questionnaires for Ocrevus Copay enrollments can be accessed by requesting questionnaire definitions from the Genentech FHIR Server.

URL to Copay Questionnaire endpoint (test): https://test-us-e1.apis.roche.com/pharma-cmg-copay-exp-test/v1/questionnaire?name=Copay Ocrevus
URL to Copay Questionnaire endpoint (stage): https://stage-us-e1.apis.roche.com/pharma-cmg-copay-exp-stage/v1/questionnaire?name=Copay Ocrevus
URLto Copay Questionnaire endpoint (prod): https://prod-us-e1.apis.roche.com/pharma-cmg-copay-exp-prod/v1/questionnaire?name=Copay Ocrevus

Ocrevus Copay Enrollment - Questionnaire Updates

Type	Available in QA (test) environment?	Product(s) impacted	linkId impacted (if applicable)	OLD	New	Comments
Addition	Yes	Ocrevus	ocrevus-form-of-ocrevus	-	"linkId": "ocrevus-form-of-ocrevus", "text": "Which form of OCREVUS is the patient taking?", "type": "choice", "required": true, "repeats": false, "answerOption": [ { "valueString": "Intravenous infusion (IV) for OCREVUS" }, { "valueString": "Subcutaneous (SC) injection for OCREVUS ZUNOVO" }	IMPORTANT: Genentech will deploy to production on evening of 2024-OCT-4. CRX will deploy a validation for this questionnaire on 2024-OCT-8.  If this question is missing from the Copay request bundle, CRX will generate an error and enrollment will not be processed.
Update	Yes	Ocrevus	ocrevus-fda-approved-indications	"linkId": "ocrevus-fda-approved-indications", "text": "Is the patient using OCREVUS for the following FDA-approved indication?",	"linkId": "ocrevus-fda-approved-indications", "text": "Is the patient using OCREVUS or OCREVUS ZUNOVO for the following FDA-approved indication?",	Change in text

Ocrevus Zunovo Copay

Ocrevus Zunovo Copay Enrollment - Questionnaires

Ocrevus Zunovo Copay questionnaires are the same as the Ocrevus Copay questionnaires but with a few additions/updates.

Type	Available in QA (test) environment?	Product(s) impacted	linkId impacted (if applicable)	OLD	New	Comments
Addition	Yes	Ocrevus Zunovo	ocrevus-zunovo-form-of-ocrevus	-	"linkId": "ocrevus-zunovo-form-of-ocrevus", "text": "Which form of OCREVUS is the patient taking?", "type": "choice", "required": true, "repeats": false, "answerOption": [ { "valueString": "Intravenous infusion (IV) for OCREVUS" }, { "valueString": "Subcutaneous (SC) injection for OCREVUS ZUNOVO" }	IMPORTANT: Genentech will deploy to production on evening of 2024-OCT-4. CRX will deploy a validation for this questionnaire on 2024-OCT-8.  If this question is missing from the Copay request bundle, CRX will generate an error and enrollment will not be processed.
Addition	Yes	Ocrevus Zunovo	ocrevus-zunovo-fda-approved-indications	-	Same Copay questionnaire configuration as Ocrevus Copay indication: "linkId": "ocrevus-zunovo-fda-approved-indications", "text": "Is the patient using OCREVUS or OCREVUS ZUNOVO for the following FDA-approved indication?", "type": "choice", "required": true, "repeats": false, "answerOption": [ { "valueCoding": { "code": "Relapsing-forms-of-multiple-sclerosis-(MS)-to-include-clinically-isolated-syndrome-relapsing-remitting-disease-and-active-secondary-progressive-disease-or-primary-progressive-forms-of-MS-in-adults", "display": "Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease or primary progressive forms of MS, in adults" } }, { "valueCoding": { "code": "no", "display": "No" } }, { "valueCoding": { "code": "unsure", "display": "Unsure" } }

Ocrevus Zunovo - BrandIds

Refer to brandIds table on Copay Value Set page

Ocrevus Zunovo - FDA Indications (ICD10)

FDA approved indications (ICD10 codes) can be found on the Access Solutions website for Ocrevus Zunovo